SIS
GSK icon

Sound Income Strategies’s GSK GSK Stock Holding History

Sound Income Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Sell
339,055
-1,419
-0.4% -$75K 0.8% 41
2026
Q1 		$19.1M Sell
340,474
-55,546
-14% -$3.01M 0.92% 33
2025
Q4 		$19.1M Sell
396,020
-16,037
-4% -$748K 0.9% 35
2025
Q3 		$17.9M Sell
412,057
-19,199
-4% -$750K 0.98% 33
2025
Q2 		$16.6M Buy
431,256
+29,197
+7% +$1.12M 0.95% 34
2025
Q1 		$15.6M Buy
402,059
+11,006
+3% +$403K 0.92% 38
2024
Q4 		$13.2M Buy
391,053
+42,140
+12% +$1.52M 0.82% 40
2024
Q3 		$14.3M Buy
348,913
+15,118
+5% +$618K 0.92% 37
2024
Q2 		$12.9M Buy
333,795
+20,472
+7% +$861K 0.8% 35
2024
Q1 		$13.4M Buy
313,323
+18,579
+6% +$766K 1% 31
2023
Q4 		$10.9M Buy
294,744
+21,913
+8% +$787K 0.91% 37
2023
Q3 		$9.89M Buy
+272,831
New +$9.68M 0.84% 33
2022
Q3 		– Sell
-67,947
Closed -$3.7M – 918
2022
Q2 		$3.7M Buy
67,947
+67,226
+9,324% +$3.71M 0.49% 55
2022
Q1 		$39K Buy
721
+11
+2% +$597 ﹤0.01% 258
2021
Q4 		$39K Hold
710
– – ﹤0.01% 259
2021
Q3 		$34K Hold
710
– – ﹤0.01% 267
2021
Q2 		$35K Sell
710
-413
-37% -$19.8K 0.01% 269
2021
Q1 		$50.1K Sell
1,123
-1,191
-51% -$54.1K 0.01% 219
2020
Q4 		$106K Sell
2,314
-80
-3% -$3.67K 0.02% 145
2020
Q3 		$113K Hold
2,394
– – 0.03% 117
2020
Q2 		$122K Buy
2,394
+439
+22% +$22.5K 0.04% 86
2020
Q1 		$93K Buy
1,955
+365
+23% +$19.5K 0.03% 85
2019
Q4 		$93K Hold
1,590
– – 0.02% 86
2019
Q3 		$85K Sell
1,590
-80
-5% -$4.12K 0.03% 85
2019
Q2 		$84K Hold
1,670
– – 0.03% 92
2019
Q1 		$87K Hold
1,670
– – 0.04% 93
2018
Q4 		$80K Hold
1,670
– – 0.04% 96
2018
Q3 		$84K Sell
1,670
-300
-15% -$15.2K 0.04% 91
2018
Q2 		$99K Sell
1,970
-182
-8% -$9.17K 0.06% 71
2018
Q1 		$105K Hold
2,152
– – 0.07% 68
2017
Q4 		$98K Buy
+2,152
New +$99.4K 0.06% 66

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sound Income Strategies's GSK Position: Q2 2026 in Review

Sound Income Strategies reduced its GSK (GSK) stake by 0.42% in Q2 2026, selling an estimated $75K and leaving 339,055 shares worth $17.8M. The position accounts for 0.8% of the portfolio, ranked #41.

Sound Income Strategies first reported a position in GSK in Q4 2017 and has held it in 31 quarters since. The position peaked at $19.1M in Q4 2025. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sound Income Strategies held 339,055 shares of GSK worth $17.8M as of Q2 2026.
  • Sound Income Strategies sold 1,419 GSK shares in Q2 2026, an estimated $75K.
  • GSK made up 0.8% of Sound Income Strategies's portfolio in Q2 2026, its #41 holding.
  • Sound Income Strategies first reported a position in GSK in Q4 2017 and has held it in 31 quarters since.
  • Sound Income Strategies's GSK position peaked at $19.1M in Q4 2025.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.